ArticleFrontiers in bioengineering and biotechnology2020

Conducting a Virtual Clinical Trial in HER2-Negative Breast Cancer Using a Quantitative Systems Pharmacology Model With an Epigenetic Modulator and Immune Checkpoint Inhibitors.

Hanwen Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.